Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank21
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-23.12M
↓ 12% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-20.72M
Historical baseline
PeriodValueYoY Change
TTM$-23.12M+51.4%
2024$-47.58M-47.0%
2023$-32.38M-28.4%
2022$-25.22M-11.8%
2021$-22.57M-62.0%
2020$-13.93M-19.1%
2019$-11.69M-2.2%
2018$-11.44M-3.8%
2017$-11.02M-33.1%
2016$-8.28M-